Very low high-density lipoproteins without coronary atherosclerosis

Miller, 1975, Plasma high-density-lipoprotein concentration and development of ischaemic heart-disease, Lancet, 1, 16, 10.1016/S0140-6736(75)92376-4 Gordon, 1989, High-density lipoprotein—the clinical implications of recent studies, N Engl J Med, 321, 1311, 10.1056/NEJM198911093211907 Brewer, 1988, Apolipoproteins and lipoproteins in human plasma: an overview, Clin Chem, 34, 4 Miller, 1987, Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis, Am Heart J, 113, 589, 10.1016/0002-8703(87)90638-7 Cheung, 1984, Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II, J Biol Chem, 259, 12201, 10.1016/S0021-9258(20)71339-6 Rader, 1991, In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I, A-II, J Lipid Res, 32, 1849, 10.1016/S0022-2275(20)41639-6 Fruchart, 1992, Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance, Clin Chem, 38, 793, 10.1093/clinchem/38.6.793 Schaefer, 1982, Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease, Arteriosclerosis, 2, 16, 10.1161/01.ATV.2.1.16 Matsunaga, 1991, Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene, Proc Natl Acad Sci USA, 88, 2793, 10.1073/pnas.88.7.2793 Schaefer, 1980, Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease), Ann Intern Med, 93, 261, 10.7326/0003-4819-93-2-261 Norum, 1989, Familial lecithin: cholesterol acyltransferase deficiency including fish eye disease, 1181 1993, JAMA, 269, 3015, 10.1001/jama.269.23.3015 Lipton, 1991, Computed tomography for patient management in coronary artery disease, Circulation, 84, 72 Rader, 1992, In vivo metabolism of a mutant apolipoprotein apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis, J Lipid Res, 33, 755, 10.1016/S0022-2275(20)41439-7 Sprecher, 1984, Two-dimensional electrophoresis of human plasma apolipoproteins, Clin Chem, 30, 2084, 10.1093/clinchem/30.12.2084 Brewer, 1978, The amino acid sequence of human ApoA-I, an apolipoprotein isolated from high density lipoproteins, Biochem Biophys Res Commun, 80, 623, 10.1016/0006-291X(78)91614-5 Warnick, 1979, Comparison of current methods for high-density lipoprotein cholesterol quantitation, Clin Chem, 25, 596, 10.1093/clinchem/25.4.596 Parra, 1990, Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates, Clin Chem, 36, 1431, 10.1093/clinchem/36.8.1431 Funke, 1991, A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities, J Clin Invest, 87, 371, 10.1172/JCI114997 Brinton, 1989, Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women, J Clin Invest, 84, 262, 10.1172/JCI114149 Warden, 1993, Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II, Science, 261, 469, 10.1126/science.8332912